Cerebral infarction is cerebral infarction, common drug treatment modalities include thrombolytic therapy, anti-platelet aggregation, plaque stabilization therapy, fiber reduction therapy, neuroprotective therapy, etc. Cerebral infarction treatment should be based on the patient’s specific condition to determine the therapeutic use of medication, and there is no so-called “best” drugs. 1. Thrombolytic therapy: it is the most important measure to restore blood flow, which can restore blood flow and improve tissue metabolism as early as possible, and promote functional recovery, and recombinant tissue-type fibrinolytic plasminogen activator is the most common thrombolytic drug. 2. Antiplatelet coagulation and plaque stabilizing drug therapy: it is suitable for ischemic stroke patients who are not eligible for thrombolytic therapy and have no contraindications such as hemorrhage, and it can be treated with antiplatelet drugs such as oral aspirin and clopidogrel as early as possible after the onset of the disease, and it is also necessary to give plaque stabilizing drugs such as riscuvastatin and atorvastatin. 3. Fiber-lowering treatment: patients with cerebral infarction who are not suitable for thrombolysis and have been strictly screened, especially those with hyperfibrinogenemia, can be treated with fiber-lowering treatment. Commonly used drugs include bacitracin, hypofibrinase and so on. 4. Neuroprotective therapy: sometimes the drugs for cell injury after acute ischemia or reperfusion can protect brain cells and improve tolerance to ischemia and hypoxia, and commonly used drugs include edaravone, cytarabine, and so on. Patients with cerebral infarction, it is recommended to seek medical treatment in time, under the guidance of physicians with medication, so as not to miss the best time for treatment, resulting in adverse consequences.